Burning Rock Biotech Ltd reports results for the quarter ended in March - Earnings Summary

Burning Rock Biotech

25/05/2021 14:32

* Burning Rock Biotech Ltd  BNR.OQ  reported a quarterly
adjusted loss of CNY1.65​​ per share for the quarter ended
in March. The mean expectation of two analysts for the quarter
was for a loss of CNY1.50 per share.
* Revenue was CNY106.62 million​;  analysts expected CNY125.90
million. 
* The mean earnings estimate of analysts had fallen by
about 18.1% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Burning Rock Biotech Ltd shares had risen by 25.0% this
quarter and gained 45.7% so far this year.
* Wall Street's median 12-month price target for Burning Rock
Biotech Ltd is CNY150.89 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated May 25 at 01:32 p.m. GMT.
​All figures in Chinese yuan renminbi